The LABVIRUS.COM Blog

[Important to note that a likely reason the WHO doesn't want to acknowledge recombination is that the audit trail will lead to a genetically-engineered LAB VIRUS that was designed to behave in such recombinant ways, thus the FRANKENVIRUS term Dr. Deagle coined back in April. The stubborn adherence to a false "random mutation" theory shows their steadfast continuing to attempt to achieve plausible deniability. It isn't working. -ed]

Fatal D225G / D225N H1N1 Co-Infections Raise Concerns
Recombinomics Commentary 15:28
December 30, 2009
http://www.recombinomics.com/News/12300903/D225G_D225N_Co.html

Current data suggests that the cases involving variant viruses in different parts of the world are unrelated and the underlying mutation events probably occurred independently from each other in the infected individuals as a consequence of the natural variability of influenza viruses and their inability to correct random coding errors.

The above comment from the ECDC report on D225G and D225N is false. The current data suggests just the opposite and indicates these changes are transmitting and jumping from one genetic background via recombination. The frequency of D225G/N in public HA sequences (about 3000) is near 1% yet in Ukraine. D225G/N is in six of six isolates from fatal cases, which has a chance of a trillion to one if events are independent and random. Moreover, the association of H225G/N with fatal or severe cases extends well beyond Ukraine.

In Sao Paulo there are four examples and all four are also from fatal cases. The published sequences have two with D225G and two with D225N. However, recent sequences with D225G and D225N in the same sample in Sweden, Mexico, and the United States have raised the possibility that the mixture is common, but selection in the sample collected or isolation of the virus leads to detection of one or the other.

For the US (Utah) case the CDC published two sequences. One, A/Utah/42/2009, was taken directly from the clinical sample and it contained mixed signals at position 1 and 2 of the codon for position 225. The other sequence was a clone from the sample which had the D225G codon at position 225, indicating the mixed signals were due to two sequences in equal proportions which had D225G and D225N. All five sequences from patients, as well as a sequence from swine in Mexico, have these tandem mixed signals, indicating the hosts are co-infected with sequences containing D225G and D225N.

In Mexico, two patients in San Luis Potosi have the mixed signals in isolates which were collected within a day of each other. The WHO working hypothesis would require that both patients were independently infected by wild type H1N1 and the H1N1 in both patients would make the same two errors in adjacent positions to generate the fatal combination of D225G and D225N. The likelihood of this happening independently in two patients in the same location at the same time is beyond remote.

This combination is also seen in Ukraine samples. Four sequences generated by Mill Hill have D225G, while two sequences generated by the CDC have D225N raising the possibility that all six fatal cases have both D225G and D225N, which would make the WHO/ECDC working hypothesis even less tenable because it would require two changes at position 225 to happen in the same patient and have those two changes as the only non-synonymous changes in these patients relative to sequences isolated from survivors.

The reliance of the WHO and ECDC on such an unlikely explanation of the data raises serious questions about data analysis by consultants so wedded to such an outdated view invoking random mutations, which is not supported by the data.

This reliance is extremely hazardous to the world’s health.

Fatal H1N1 Tamiflu Resistance in New Brunswick Canada
Recombinomics Commentary 00:20
December 30, 2009
http://www.recombinomics.com/News/12300902/H274Y_NB_Canada.html

New Brunswick public health officials are reporting the province’s first death related to a drug-resistant H1N1 strain.

A 27-year-old Quispamsis man died in hospital on Monday after nearly a month in intensive care, public health officials said. Doctors tried treating him with the anti-viral drug Tamiflu but those efforts failed.

According to Van Buynder, the H1N1 strain the man contracted was resistant to drugs such as Tamiflu that are used to fight the virus.

The above comments describe another fatal case linked to Tamiflu resistant H1N1. Although the explosion in Tamiflu resistance has been reported across the northern hemisphere, there has also been a spike in fatal cases linked to H274Y. The fixing of H274Y in seasonal flu was tied to hitchhiking of H274Y with receptor binding domain changes. A193T was in all isolates, and was associated with one of more additional changes at positions 187, 189, and 196.

In pandemic H1N1, H275Y has been found in association with receptor binding domain changes at position 225 (D225E and D225G). D225G has been closely linked to fatal and severe cases, so H274Y linked fatalities raise concerns that such outcomes signal H274Y on a sequence that not only is fit, but is also lethal.

Recent fatal cases of Tamiflu resistance include three patients at Duke Medical Center and addition deaths in Delaware, South Korea, the Netherlands, and France. The death in France also had D225G.

H1N1 Tamiflu Resistance Lesson Not Learned
Recombinomics Commentary 00:20
December 30, 2009
http://www.recombinomics.com/News/12300901/H274Y_LNL.html

Dr. Nancy Cox isn’t convinced H3N2 is going away. But the head of the influenza division of the U.S. Centers for Disease Control would be happy with a one-for-one exchange, with the pandemic H1N1 replacing the seasonal virus of the same name.

That’s because seasonal H1N1 viruses are resistant to oseltamivir (Tamiflu), the main drug used to fight flu.

The pandemic H1N1 viruses are susceptible to Tamiflu, though they are resistant to two older flu drugs, amantadine and rimantadine. Those two drugs aren’t widely used anymore because resistance to them develops easily.

Swapping viruses that are immune to Tamiflu for ones the drug works against would be a bargain, Cox suggests. “Getting rid of resistance in circulating H1N1 viruses would be a real silver lining.”

The above comments on replacing seasonal H1N1 where H274Y is fixed, with pandemic H1N1 where H274Y is becoming fixed, signals a lesson not learned. H274Y in seasonal H1N1 went from 0% to 100% in one season in several countries. In the US it went from 10% to 100%. Although the process began in 2006 when H274Y was first identified in seasonal H1N1 in patients who had not been treated with Tamiflu. H274Y jumped from one seasonal flu genetic background to another via recombination, as did severall additional polymorphism which jumped from clade 2C to clade 2B to create the strain that emerged in 2008.

The repeat in pandemic H1N1 may be much quicker because the widespread use of Tamiflu creates additional selection pressure for H274Y to pair with receptor binding domain changes that also drive selection. The recent reports of H274Y transmission in Vietnam and hospitals in North Carolina and Wales, along with an explosion in the detection of H274Y worldwide, suggest that the fixing of H274Y may be well on its way in the next wave, which may begin in the upcoming weeks.

The latest CDC weekly report on influenza does provide support for the crowding out of seasonal H1N1, as well as seasonal H3N2. No isolates of either sero-type were identified, and there were only 3 influenza B isolates. In contrast, a year earlier there were 103 isolates, most of which were H1N1, but even influenza B was 10 fold higher than this year.

However, most flu cases usually appear in the winter, when the virus is stable and host resistance is compromised by cold weather and other respiratory diseases. Thus, it is likely that an influenza virus will emerge, but seasonal flu is virtually absent throughout the northern hemisphere. Thus although swine H1N1 in the US and across the northern hemisphere is declining, there are still high levels of pandemic H1N1 in circulation. In the US the week 50 levels of swine H1N1 were still three fold higher than seasonal flu last year, and 100 fold higher than seasonal flu this year. In Ukraine, deaths have spiked higher raising concerns of multiple pockets of pandemic H1N1 that can fill the seasonal flu void in the upcoming months.

Thus, the potential for H274Y to become fixed in the next wave is quite real because competing seasonal flu strains are not circulating, and competing swine H1N1 that is Tamiflu sensitive is on the decline. However, not only can swine H1N1 fill the upcoming void with H274Y, there are additional signs that receptor binding domain changes at position 225 are also emerging. Mill Hill has reported H1N1 with D225G as a low reactor, signaling a selective immunological advantage over wild type. Both D225G and D225N have been associated with severe and fatal cases, so the emergence of swine H1N1 with H274Y and D225G/N could be CATASTROPHIC.

This, the silver-lining in the replacement of seasonal H1N1 with pandemic H1N1 may lead to a result that contains no silver lining, other than another example of influenza evolution via recombination, instead of the random mutation explanation of the detection of D225G/N on multiple H1N1 genetic backgrounds.

Ukraine Fatalities Spike to 675 – Two Day Total 42
Recombinomics Commentary 20:08
December 29, 2009
http://www.recombinomics.com/News/12290902/Ukraine_675.html

3,669,751 Influenza / ARI
207,013 Hospitalized
675 Dead

The above figures are from the Ukraine Ministry of Health and represent a spike of 42 fatalities in the past 48 hours. Oblast reporting 5 or more fatalities in the past 2 days includes Donetsk (7 to 80), Kharkiv (6 to 29), Dnipropetrovsk (5 to 32), Cherkasy (5 to 25) and Crimea (5 to 13). The increases to 20 fatalities per day are close to the levels when the outbreak was first reported in late October (see map).

Samples collected from the fatal cases had two receptor binding domain changes, D225G and D225N, which have also been associated with fatality rates of 100% in Brazil, Mexico, and France. However, the results from the first 6 cases in Ukraine represents the largest number from any country and additional examples are expected since the six cases were from at least two Oblast and were in individuals who were not contacts of each other.

A preliminary report by WHO and ECDC has suggested that the presence of D225G and D225N in the fatal cases is due to random copy errors, even though the cases in Ukraine involve two different changes, which represent the only non-synonymous HA differences between the fatal and recovered cases, and recently patients with both changes have been identified in the United States (Utah), Sweden (Stockholm), and Mexico (San Luis Potosi). The samples from the two cases in San Luis Potosi were collected within a day of each other. The same clustering in time and space was seen Ukraine, but on a different H1N1 genetic background.

The recent surge in fatal cases should allow for additional sample collection over a two moth time frame to allow for more extensive analysis, which will highlight the failure of random mutations to explain the dangerous polymorphisms, D225G and D225N, on multiple genetic backgrounds.

The WHO Surprise on D225G / D225N H1N1 Fatalities
Recombinomics Commentary 17:48
December 29, 2009
http://www.recombinomics.com/News/12290901/D225G_D225N_Surprise.html

After considering the current available virological, epidemiological and clinical findings and following discussions on an earlier draft with WHO and its European-based Collaborating Centre ECDC has come to a preliminary formulation namely that the G222D/N variants exist in a small proportion of sporadic severe, as well as mild cases of 2009 pandemic
influenza A(H1N1) infection and that these represents natural variation of the virus with no special association with severity of the disease course. As such and while they do not transmit they should have a minimal impact on public health and pandemic response. Current data suggests that the cases involving variant viruses in different parts of the world are unrelated and the underlying mutation events probably occurred independently from each other in the infected individuals as a consequence of the natural variability of influenza viruses and their inability to correct random coding errors. However because of that inherent variability and ability to surprise the 2009 A(H1N1) will need on-going combined virological, epidemiological and clinical surveillance and study.

The above comments in the latest ECDC report confirm attempts by WHO consultants to explain the strong association of D225G and D225N (aka D222G and D222N) with fatal and severe H1N1 cases as “random coding errors” even though the WHO regional lab in Mill Hill found D225G in four of four fatal cases, while the WHO region lab in Atlanta (CDC) found D225N in two of two additional cases, which were almost certain fatal cases also.

D225G and D225N are rare and have been reported in about 1% of H1N1 HA sequences, yet they have a 100% case fatality rate in sequences from Ukraine. This 100% CFR was matched in several additional countries, including two D225G and two D225N sequences in Brazil (Sao Paulo), as well as two D225G sequences in France and three recent sequences (1 D225G and 2 D225N) in Mexico. Moreover, recent sequences with mixed signals for both D225G and D225N have been found in 1 fatal case in the US (Utah), 2 fatal cases in Mexico (San Luis Potosi) and one severe case in Sweden (Stockholm). Similarly, Denmark, who filed a formal notification when three examples were identified and two were fatal while the third was severe, has a high rate.

Although there were a few mild cases with D225G in the US at the start of the pandemic last spring, including the vaccine target California/7, mild cases are common at the start of a pandemic because there is little immunity in the target population, and infections and symptoms can be caused by low viral loads which are effectively contained by a weak host response. The association of D225G and D225N is severe and fatal cases since the summer has been remarkable, especially since the vast majority of pandemic H1N1 infections are mild and resolve without treatment. In contrast, nearly 100% of recent cases with D225G, D225N, or both have been fatal or severe.

In Ukraine five isolates from patients who recovered had a wild type receptor binding domain, while six patients who were infected by the same sub-clade had either D225G in the four known fatal cases or D225N in the two likely fatal cases. This rate of 100% of six patients is not associated with six independent random errors in six patients, who died in the same general area at the same time, and only affects the position 225 codon.

This “random mutation” paradigm constantly produces “surprises”, for which the above “experts” readily acknowledge on a very regular basis. They were surprised and baffled by H274Y Tamiflu resistance in patients infected with seasonal H1N1, and will again be surprised and baffled by the same result in pandemic H1N1.

WHO’s reliance on consultants who try to use random mutation to explain these examples of 100% case fatality rates in multiple countries is cause for increasing concern. [NO KIDDING. WHO do they think they're kidding (pun intended)? -ed]

People of Hawaii Pass Resolution Against Forced Vaccination
Posted by: Dr. Mercola
December 29 2009 | 15,053 views
http://articles.mercola.com/sites/articles/archive/2009/12/29/People-of-Hawaii-Pass-Resolution-Against-Forced-Vaccination.aspx

Department of Health officials in Hawaii were overruled by County of Hawaii directors supporting a resolution favoring First Amendment constitutional rights and vaccination exemptions for everyone demanding them.

The nearly unanimous vote demonstrated the power of local community activists to rebuke “top down” policies advancing “mandatory” vaccinations during declared emergencies.

The Resolution urges State and Federal legislators in Hawaii “to amend vaccine laws to include medical, religious, and philosophical exemptions from any vaccine program,” including those declared urgent by health officials.

This county resolution has yet to play out in Hawaii’s state politics, but, it is a good, solid example of what local municipalities can do to assert their sovereign authority over the territory they are elected to represent.

It shows that, finally, we have some local government officials who not only are listening to their constituents, but who realize that they can, and should, stand up against over-reaching, martial law-type State and Federal mandates.

‘A Victory for Health Freedom’

The Hawaii Tribune Herald tried to bury the news of the Resolution in its December 4 story titled, “Flu Mist Is Better than No Vaccine.” But online blogs and news watchers picked it up. Across the Internet, the resolution’s sponsor, Hawaii County councilwoman Emily Naeole-Beason, has been quoted as saying,

“This is a victory for health freedom, common sense, and US constitutional entitlements. I am very proud of our Council who put public safety ahead of special interests.”

I couldn’t agree more, and we need more representatives like Naeole-Beason in public office. This feisty councilwoman from Hawaii has turned the tables on the FDA, CDC and the World Health Organization, as well as state and federal governments, by using their own argument for mass vaccination against them, and making it a defense for the public’s constitutional right to choose!

For too long, with no matter what vaccine was being questioned, government health officials around the world have defended mass vaccination with the mantra that they’re doing it in the interest of public safety.

In the US and abroad, anyone who dared to question, criticize or protest this mantra and the state-mandated vaccines it promoted was labeled as selfish, and accused of putting special interests ahead of the public good. No matter that some people just wanted the right to be as informed as possible about vaccines’ safety and risks – if they questioned the powers-that-be, they were against public safety.

Naeole-Beason, backed by her council, has dared to challenge the status quo and publicly say what many of us have been saying for years – that it’s really the government officials who are putting special interests ahead of public safety, not the other way around.

[snip]

Others are Asserting Their Right to Choose

The Hawaii Resolution is printed in full here at bigislandchronicle.com. What I find very interesting is that the Resolution is not just about the H1N1 vaccine, which prompted it, but is about ALL vaccines.

It quotes the Hawaii statute which, like the other US states’, shields the pharmaceutical industry from lawsuits stemming from injuries of vaccines given during a state-declared emergency, but then it goes on to say:

“WHEREAS, there is insufficient scientific evidence proving that vaccines are safe or effective, therefore it is not in the best interest of public health to impose mandatory vaccinations without exemptions; and

WHEREAS, swine flu and the flu vaccines both contain Thimerosal, a preservative for vaccines composed of mercury, one microgram of mercury is considered toxic and flu shots contain 25 micrograms. By age two, most United States children have received around 237 micrograms of mercury through vaccines; and

WHEREAS, the fast tracked government vaccines contain a substance called squalene that is suspected of causing serious long-term damage to the body; and

WHEREAS, in the wake of potential harm to the individual and the public from vaccinations, and the vacillating interpretation of “vaccine science,” it is in the public’s best interest to amend the vaccine laws, to include the right of medical, religious, and philosophical exemptions from mandated vaccination programs; now, therefore,

BE IT RESOLVED BY the COUNCIL OF THE COUNTY OF Hawai‘i, that it recommends that state and federal elected officials who represent the people of the State of Hawai‘i amend vaccine laws to include medical, religious, and philosophical exemptions from mandatory vaccine programs that contain thimerasol or squalene.

BE IT FURTHER RESOLVED, that any vaccine known to contain harmful viruses or any materials known to prompt autoimmune diseases or cancer risks shall provide cause for exemption for any person in the State of Hawai‘i who so desires such exemption.”

What a powerful, in-your-face proclamation this is to all the officials who want to overrule the rights of individuals and communities to govern themselves!

The good thing about this is that the community activists in Hawaii are not alone. Slowly but surely, across the US, people who are sick and tired of being told that they have to accept mandated vaccines for themselves and their children are standing up for their rights.

For example, in Idaho, public citizens are demanding that the governor grant them the right to exemptions from mandated vaccinations.

In Washington state 16,000 registered nurses filed a federal lawsuit to stop MultiCare Health System from implementing a mandatory flu vaccination policy for them. This action “blatantly ignores their legal obligation to bargain with the union,” was the comment that Barbara Frye, the nurses’ association’s assistant executive director said, in explaining why the lawsuit was filed.

In New York state, a judge halted enforcement of a law that mandated health care workers there be vaccinated against H1N1 – even in the face of the state health commissioner who, like his colleagues, repeated the public safety mantra.

And in New Jersey – home to vaccine giant Merck – parents staged rallies against a state mandate requiring all children be vaccinated against H1N1.

These are just a few examples of vaccine community action movements that have begun across the country. I can’t tell you how pleased I am to see that people are finally starting to see the bigger picture, and in ever increasing numbers are starting to demand more information. People are finally asking to be fully informed, and are demanding the right to be able to make a choice with that information.

What You Can Do

I urge you to continue educating yourself about vaccines, and the diseases they’re designed to treat. The National Vaccine Information Center is one of the best online sources for your continued research on this topic [after LABVIRUS.COM and falseflagflu.com among others, of course. -ed] . Remember these two axioms as the foundation of everything you do:

1. Nobody, anywhere or any time and under any circumstances has the right or power in this country to immunize you or your children against your will and conviction. If they attempt to do so, you can legally charge them with “assault with a deadly weapon” and have the full resources of our laws behind you.

2. At all times in attempting to avoid unwanted immunization, you have the Law of the Land behind you. Those who would try to vaccinate you against your will are on very shaky ground. Into every compulsory immunization law in America are written legal exceptions and waivers which are there specifically to protect you from the attempted tyranny of officialdom. It is not only your right, but your obligation to use them, if this is what your conscience tells you.

For more information about how to legally avoid unwanted immunizations of all kinds, please review my previous article How to Legally Avoid Unwanted Immunizations of All Kinds.

[Reader proceed with caution. Learn the rules of court through Jurisdictionary and be able to properly file your own injunctions when the time comes. -ed]